Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Singaraja Putra Tbk. (SINI)

UBC Medical Indonesia Tbk.Trading
Singaraja Putra Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Singaraja Putra Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb), sedangkan Singaraja Putra Tbk. diperdagangkan di Rp7.000 (kapitalisasi pasar 8,51 T, volume 24 jam 514,5 rb). Perbedaan utamanya: Singaraja Putra Tbk. jauh lebih besar — sekitar 13,4× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (843 rb vs 514,5 rb). Mana yang lebih baik tergantung tujuan investasimu.

LABSSINI
Kapitalisasi Pasar
635,95 M8,51 T
Volume
843 rb514,5 rb
Lot
8,43 rb5,15 rb
Perputaran
137,6 jt3,57 M
Harga Rata-rata
163,226.930,23
Nilai Transaksi
137,6 jt3,57 M
Harga Ekuilibrium Indikatif
1657.000
Volume Ekuilibrium Indikatif
246469

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail
SINI
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Singaraja Putra Tbk.

PT Singaraja Putra Tbk (the Company) was established based on Notarial Deed No. 52 dated November 23, 2005 of Notary Sri Herawati Anwar Effendi, S.H. The Company commenced commercialoperations in 2006.

Selengkapnya di halaman SINI